Artificial intelligence (AI) software developer Quantib, based in Rotterdam in The Netherlands, has released an upgrade to its software for MRI quantification of brain atrophy and white-matter hyperintensities.
Designed to support radiologists in interpreting brain MRI scans, Quantib ND 2.0 measures brain atrophy and detects white-matter hyperintensities. These changes in the brain are related to, for example, aging, dementia, and multiple sclerosis, according to the vendor.
The upgrade includes the following:
- Automatic atrophy analysis
- Automatic longitudinal atrophy and longitudinal WMH analyses
- Easy review and, if necessary, editing of WMH segmentation in an internet browser
- Clear overviews of quantitative results in a report per analysis
- Segmentations in DICOM secondary capture format
Quantib received U.S. Food and Drug Administration clearance for the software in January 2019.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
